Made in Russia

All regions
ENG
Top stories

A single-component vaccine against coronavirus was registered in Russia

20
A single-component vaccine against coronavirus was registered in Russia

The Ministry of Health registered a single-component vaccine against coronavirus infection Sputnik Lite.

According to the Russian Direct Investment Fund, the effectiveness of the new drug was 79.4% four weeks after immunization. This efficacy rate is higher than a number of other vaccines that are made in two phases.

The first and second phases of safety and immunogenicity studies of Sputnik Lite started in January, and interim results were summarized in mid-March. The third phase takes place in Russia, UAE, Ghana and a number of other countries, with seven thousand participants. By the end of the month the interim data of this phase will be summarized.

However, laboratory studies, according to the developer, have already indicated the effectiveness of the drug against all the new strains of coronavirus.

It is noted that Sputnik Lite does not require special conditions for storage and logistics, and the price of the vaccine does not exceed ten dollars.

Made in Russia // Made in Russia

Author: Ksenia Gustova

0